Homologous recombination deficiency and platinum rechallenge in platinum-resistant ovarian cancer patients.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.5576
Abstract: 5576Background: Ovarian carcinomas show homologous recombination deficiency (HRD) in up to 50% of cases and in 15 to 20% of cases occur due to germline BRCA1 or BRCA2 mutations. BRCA mutated tumors... read more here.
Keywords: recombination deficiency; homologous recombination; platinum; deficiency platinum ... See more keywords